BERARDI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 113
NA - Nord America 106
AS - Asia 46
SA - Sud America 2
Totale 267
Nazione #
US - Stati Uniti d'America 106
RU - Federazione Russa 44
IT - Italia 33
IE - Irlanda 24
SG - Singapore 14
HK - Hong Kong 13
JO - Giordania 9
SE - Svezia 8
CN - Cina 5
IN - India 5
BR - Brasile 2
HR - Croazia 2
FI - Finlandia 1
UA - Ucraina 1
Totale 267
Città #
Dublin 24
Fairfield 10
Florence 10
Hong Kong 10
Altamura 8
Ashburn 8
Lawrence 8
Chandler 7
Rome 7
Singapore 7
Houston 6
Wilmington 6
Boston 4
Cambridge 4
Mumbai 4
Princeton 4
Santa Clara 4
Seattle 4
Woodbridge 4
San Diego 3
Boardman 2
Buffalo 2
Hillsboro 2
Kent 2
Milan 2
Moscow 2
São Paulo 2
West Jordan 2
Zagreb 2
Helsinki 1
Lucca 1
Mountain View 1
Norwalk 1
Pune 1
Romola 1
Shanghai 1
Venezia 1
Totale 168
Nome #
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 79
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study 46
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 46
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 42
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 38
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 25
Totale 276
Categoria #
all - tutte 1.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 6 0
2020/202117 2 0 3 1 0 0 0 2 1 4 4 0
2021/202235 0 0 6 4 0 5 0 5 2 1 3 9
2022/2023100 7 16 3 14 3 14 13 6 13 2 5 4
2023/202443 1 3 5 5 1 3 4 12 0 4 4 1
2024/202575 13 42 20 0 0 0 0 0 0 0 0 0
Totale 276